Cardiogenetics 2019-05-22T17:31:40+02:00 Paola Granata Open Journal Systems <p><strong>Cardiogenetics</strong>&nbsp;publishes high quality original research papers, review articles, short reports, news and views, with the aim of connecting the scientific (bench) to the clinical (bedside) world.</p> <p>As an essential resource to general physicians, cardiologists, and geneticists,&nbsp;<em>Cardiogenetics</em>&nbsp;primary purpose is to report Original Research in the following areas: Clinical and molecular aspects of inherited heart diseases (IHDs): genotype-phenotype findings; follow-up data from IHD clinics; clinical findings from large and informative families with IHDs; studies on molecular imaging in IHDs; Clinical and molecular aspects of rare diseases: clinical, imaging and molecular findings of rare diseases (RDs) with cardiovascular involvement; Pharmacogenetics and Pharmacogenomics: studies involving new drugs or well known therapies in IHDs, RDs, and cardiovascular medicine; genetic/genomic profile and response to therapies; Stem cells studies: clinical trials and experimental studies involving cell studies/cell therapy.</p> <p>A space will be given to negative studies in cardiogenetics: this space will be dedicated to clinical, molecular, cellular, pharmacological studies with a solid scientific background, but leading to negative results.</p> <p><strong>Cardiogenetics</strong> will also welcome: Review articles: To be oriented towards all the aspects of cardiogenetics (clinical, molecular, cellular, pharmacological); Clinical and Experimental Cases/Hypothesis: Clinical (single) cases regarding IHDs or RDs; single experimental design with positive and/or negative results; Methods and Techniques: Experimental plan and/or new techniques in the field of molecular genetics, stem cells, pharmacogenomics, etc; Images in Cardiogenetics: Images and/or videos regarding “particular” clinical features, molecular imaging, and experimental (molecular, etc.) results; News and Views: commentary, summary, reports of outstanding articles in other journals for the general public; Interactive Clinical Cases: Interesting cases with 3-5 questions.</p> <p class="p1"><span class="s1">This journal does not apply charge for publication to Authors as it is supported by institutional funds.</span></p> Response to Skinner: Risk stratification in hypertrophic cardiomyopathy: Time to think about the electrocardiogram 2019-05-22T17:31:37+02:00 Juan Pablo Kaski <p>Not available</p> 2019-04-24T16:58:52+02:00 ##submission.copyrightStatement## Risk stratification in hypertrophic cardiomyopathy: Time to think about the electrocardiogram 2019-05-22T17:31:38+02:00 Jonathan R. Skinner <p>Not available</p> <p>&nbsp;</p> 2019-04-24T16:58:34+02:00 ##submission.copyrightStatement## Atrial myxoma and Williams-Beuren syndrome. An incidental association? 2019-05-22T17:31:39+02:00 Giuseppe Limongelli Fiorella Fratta Annapaola Cirillo Adelaide Fusco Tommaso Marrazzo Stefania Tramonte Martina Caiazza Giuseppe Caianiello Maria Giovanna Russo <p>We report the case of a 15 years old girl with Williams-Beuren syndrome and atrial mixoma.</p> 2019-04-17T15:59:41+02:00 ##submission.copyrightStatement## Reverse Takotsubo syndrome, a case report of a rare cause for postpartum heart failure 2019-05-22T17:31:40+02:00 Leo Kilian Philip Haaf Otmar Pfister Annina S. Vischer Olav Lapaire Thilo Burkard Predominant causes for newly diagnosed postpartum heart failure are preeclampsia and peripartum cardiomyopathy. Being an anatomical variant of Takotsubo syndrome (TTS) reverse TTS in this period is rare. We present a 36 year old patient, who had delivered triplets by cesarean section. Because of postpartum bleeding she was administered sulprostone. Later she was transferred to the Intensive Care Unit with sudden development of dyspnea, tachypnea and tachycardia. Clinical symptoms, laboratory findings and chest radiograph showed signs of acute heart failure. Transthoracic echocardiography (TTE) revealed reverse TTS with moderately reduced left ventricular ejection fraction (LVEF 39%). The patient stabilized with loop diuretic, angiotensine-converting enzyme inhibitors and beta-blockade. Breast-feeding was discouraged and bromocriptine administered. Left ventricular function normalized (LVEF 60%) within four weeks. TTS should be considered in patients with early postpartum development of heart failure. Rapid cardiac recompensation after the start of adequate therapy and complete resolution of clinical symptoms and TTE findings are typical for postpartum TTS. 2018-10-02T15:58:11+02:00 ##submission.copyrightStatement##